Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach

Rutaiwan Tohtong

          Cholangiocarcinoma (CCA) has a complex immune microenvironment architecture, thus possessing challenges in its characterization and treatment. This study aimed to repurpose FDA-approved drugs for cholangiocarcinoma by transcriptomic-driven bioinformatic approach. We derived an immune-oncogenic signature consisting of 26 mortality-associated genes. Read More …

BC Faculty Seminar: October 6, 2021

Rutaiwan Tohtong

BC Faculty Seminar “Therapeutic Potential of Ceritinib in Cholangiocarcinoma” by Prof. Rutaiwan Tohtong Department of Biochemistry, Faculty of Science, Mahidol University Join WebEx Meeting https://mahidol.webex.com/mahidol/j.php?MTID=m1c1dfe36aa68e5f8df5c9736d4f2d721 Meeting number: 2642 451 3662 Password: oct2021